Under construction – not a live service
Sign in
Taking peopleNo phase

Kidney Biopsies to Study Kidney Problems After Liver Transplant

Studies kidney biopsies in adults with liver transplants and reduced kidney function.

Plain-language title generated from the registry record
Registry title: Renal Biopsies in Post-liver Transplantation Patients With Renal Impairment

Key facts

Where
Shanghai, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

Source: NCT05326399, who can take part

Where in China

  • Ren Ji Hospital, Shanghai Jiao Tong University School of MedicineShanghai, ChinaNot yet recruiting

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
RenJi Hospital
Trial code
NCT05326399
Record updated
28 November 2025
Original description
Investigators will conduct this single-center, prospective cohort study to explore the prevalence and risk factors of renal function progression in post-liver transplantation patients with renal impairment after renal biospy and to understand the the pathology of kidney disease in post-liver transplantation patients with renal impairment.Read full original descriptionShow less

Renal Biopsies in Post-liver Transplantation Patients With Renal Impairment: a Single-center, Prospective Cohort Study

Investigators will conduct this single-center, prospective cohort study to explore the prevalence and risk factors of renal function progression in post-liver transplantation patients with renal impairment after renal biospy and to understand the the pathology of kidney disease in post-liver transplantation patients with renal impairment.

Inclusion: age 18-75 years; patients received liver transplantation; new onset of proteinuria(defined as 24-hour proteinuria>1g/24h, or Urinary albumin creatinine ratio(UACR)>300mg/g on at least two occasions), and/or renal impairment: eGFR <60 mL/min/1.73 m² at least two occasions, and/or serum creatinine increase ≥50% from baseline; have received renal biopsy in the past 3 months; Signed informed consent form(ICF).

Exclusion: patients received renal transplantation; hepatic failure; uncontrolled mental disease or unable to cooperate during operation; severe bleeding risk or platelet <70*109/L; chronic kidney insufficiency with eGFR<30ml/min·1.73m2,or kidney atrophy, or solitary kidney, or medullary sponge kidney, or polycystic kidney, or obstructive nephropathy; Pregnancy or lactation; not suitable for this study judged by investigaters.

ClinicalTrials.gov NCT05326399